Ken Paxton's lawsuit argues that the Pfizer COVID vaccine was less than 1 percent effective at fighting the disease.
Parents struggle to find newly-approved RSV vaccine for babies. Pediatrician explains why. Parents struggle to find newly-approved RSV vaccine for babies. Pediatrician explains why. 03:27 ...
Amid a shortage of a highly sought-after and brand-new vaccine, President Joe Biden's administration has expedited shipment of an additional 75,000 doses. Senior officials told Scripps News ...
The California Department of Public Health (CDPH) recently published an article stating, “Influenza, respiratory syncytial virus (RSV) and COVID-19 are circulating this fall, but not yet at the rate t ...
A first of its kind vaccine has been approved by the FDA to prevent infections with the chikungunya virus. The virus is most prevalent in semi-tropical and tropical areas, such as Central and ...
Nov. 16 (UPI) --The CDC said Thursday it is releasing more than 77,000 more doses of the RSV monoclonal antibody vaccine Beyfortus, designed to protect infants from severe effects of the ...
Nov 9 (Reuters) - The U.S. Food and Drug Administration (FDA) on Thursday approved Valneva's (VLS.PA) single-shot vaccine for individuals 18 years of age and older who are at increased risk of ...
The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. Food and Drug Administration on Thursday. The single-dose shot, known as Ixchiq, is approved for adults ...
According to the lawsuit, Pfizer misrepresented the effectiveness of the vaccine and also tried to censor public discussion ...
Nov. 10, 2023 -- The FDA on Thursday approved the first vaccine for the chikungunya virus, which is transmitted to humans through mosquito bites. The vaccine, called Ixchiq and produced by Valneva ...
The Food and Drug Administration said it granted approval of Ixchiq, the first vaccine for chikungunya virus, to Valneva Austria. Valneva Austria's parent company is France's Valneva SE.
